<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03389282</url>
  </required_header>
  <id_info>
    <org_study_id>AZ 277/2013BO2</org_study_id>
    <nct_id>NCT03389282</nct_id>
  </id_info>
  <brief_title>Metabolites of Tear Fluid</brief_title>
  <acronym>Metabol-T</acronym>
  <official_title>Metabolites of Tear Fluid - Evaluation in a Clinical Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute of Ophthalmic Research Tuebingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institute for Clinical Epidemiology and Applied Biometry Tuebingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The pilot trial evaluates the use of modified Schirmer strips and is designed to evaluate
      inter-individual range of metabolites in tear film.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The variability of tear film metabolites should be investigated in a sample of
      ophthalmologists in preparation for a pilot study in patients eye diseases.

      The easy accessibility of the tear fluid and the lack of invasiveness of the study make it
      promising and sensible to determine the concentration of various tear film metabolites.
      Because attention has so far focused primarily on the quantitative and qualitative analysis
      of tear film proteins, many metabolites have so far only been shown to be contained in tears.

      However, before the suitability of the measured values as a predictive parameter of the
      ocular surface for pathologies can be examined and assessed, it is necessary to determine the
      scattering variables in a sample of healthy volunteers. Thus, reference areas are to be
      defined for later investigations in order to enable reliable case number planning thereafter.

      Repeated determinations at different times and on different days make it possible in
      particular to detect a time-dependent relationship in view of the dynamic variability of the
      tear film. The functional significance of certain metabolites can not yet be assessed in the
      establishment phase. However, the data may provide important information for the
      interpretation of a later, planned feasibility study with diseased patients or the influence
      of applied eye drops.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2013</start_date>
  <completion_date type="Anticipated">April 1, 2018</completion_date>
  <primary_completion_date type="Actual">December 1, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>concentration of analytes (lipids, proteins/amino acids)</measure>
    <time_frame>3 days per patient</time_frame>
    <description>level of analytes (ng/ml)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of detecatable analytes</measure>
    <time_frame>3 days per patient</time_frame>
    <description>number of analytes (lipds, proteins/amino acids)</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Healthy Subjects</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Tear Sampling</intervention_name>
    <description>comprehensive eye exam, Schirmer test, break-up time, tear sampling</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tear fluid
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        healthy volunteers without any eye condition and normal anterior surface
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy subjects at age &gt; 18 years

        Exclusion Criteria:

          -  in the case of subjects with a mental disability or legal guardianship, due to
             possible conflicts for the caregivers, a data evaluation and recording should in
             principle be dispensed with.

          -  subjects who have had any eye drops within the last 4 weeks, e.g. lubricants were used

          -  subjects undergoing clinical examination for symptoms of wetting disorder or
             morphological changes related to eye disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Focke Ziemssen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for Ophthalmology, University of Tuebingen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Focke Ziemssen, MD</last_name>
    <phone>+49 7071 29 84762</phone>
    <email>focke.ziemssen@med.uni-tuebingen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sascha Dammeier, PhD</last_name>
    <phone>+49 7071 29 84955</phone>
    <email>sascha.dammeier@uni-tuebingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Tuebingen</city>
        <state>BW</state>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Focke Ziemssen, MD</last_name>
      <phone>0049 7071 29 84761</phone>
      <email>Focke.Ziemssen@med.uni-tuebingen.de</email>
    </contact>
    <investigator>
      <last_name>Focke Ziemssen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2017</study_first_submitted>
  <study_first_submitted_qc>January 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 3, 2018</study_first_posted>
  <last_update_submitted>January 2, 2018</last_update_submitted>
  <last_update_submitted_qc>January 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tear, Metabolite</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

